Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent
Objective: The endocannabinoid (eCB) system is increasingly recognized as being crucially important in obesity-related hepatic steatosis. By activating the hepatic cannabinoid-1 receptor (CB1R), eCBs modulate lipogenesis and fatty acid oxidation. However, the underlying molecular mechanisms are larg...
Main Authors: | Shahar Azar, Shiran Udi, Adi Drori, Rivka Hadar, Alina Nemirovski, Kiran V. Vemuri, Maya Miller, Dana Sherill-Rofe, Yhara Arad, Devorah Gur-Wahnon, Xiaoling Li, Alexandros Makriyannis, Danny Ben-Zvi, Yuval Tabach, Iddo Z. Ben-Dov, Joseph Tam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877820301617 |
Similar Items
-
CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
by: Adi Drori, et al.
Published: (2020-11-01) -
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats
by: Dimitris Spyridakos, et al.
Published: (2022-12-01) -
Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans
by: Anna Permyakova, et al.
Published: (2023-09-01) -
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB<sub>2</sub> receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy
by: Deng Liting, et al.
Published: (2012-09-01) -
Are CB2 Receptors a New Target for Schizophrenia Treatment?
by: Isadora L. Cortez, et al.
Published: (2020-10-01)